SIRIO(SZ:300791)2024-07-21 07:34Financial Performance - The company expects net profit attributable to shareholders for the first half of 2024 to be between 146.72 million and 161.90 million yuan, representing a growth of 45% to 60% compared to the same period last year, which was 101.19 million yuan [2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be between 144.05 million and 158.95 million yuan, also reflecting a growth of 45% to 60% from last year's 99.35 million yuan [2]. - The estimated impact of non-recurring gains and losses on net profit attributable to shareholders is approximately 300,000 yuan [4]. Business Strategy - The company is benefiting from a collaborative system in R&D, supply chain, and sales across China, the US, and Europe, contributing to overall performance growth [7]. - The company is committed to an "internationalization" strategy, leveraging the advantages of its German and Best Formulations factories to expand overseas business [12].